Cecilie Delphin Amdal

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV

Susanne Singer, Cecilie Delphin Amdal, Eva Hammerlid et al. · Head & Neck · 2019 · 141 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +12

Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial

Cecilie Delphin Amdal, Anne-Birgitte Jacobsen, Berit Sandstad et al. · Radiotherapy and Oncology · 2013 · 52 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study

Cecilie Delphin Amdal, Kristin Bjordal, Guro Lindviksmoen Astrup et al. · International Journal of Cancer · 2024 · 42 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +11

Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View

Cecilie Delphin Amdal, Kristin Bjordal, Guro Lindviksmoen Astrup et al. · Healthcare · 2023 · 36 citations · Full text

Medicine, Oncology, Radiation Oncology +13